Table 4.
Type | Name | Preparation Technique | Fluorine Component | Characterisation * | Pros and Cons | Application | Ref |
---|---|---|---|---|---|---|---|
POLYMERIC | Fluorous colloidal NPs | Copolymer by ATRP. NPs formation by self-assembly to micelle | Trifluoroethyl methacrylate | DLS (260 nm), TEM, FMRI, FC, CM, UV-Vis, CyA–on macrophage cells, animal studies–female athymic NCR nude mice for breast cancer | Simple preparation of copolymer | Immune cell tracking and systemic disease monitoring | [187] |
No surfactant | |||||||
Little off target accumulation | |||||||
Tumour-homing | |||||||
Poly(OEGA-co-TFEA)-b-poly(St-co-VBA) | Polymerisation by RAFT and NPs by PISA | 2,2,2-trifluoroethyl acrylate | FMRI and NMR, DLS, TEM, CM | Little or no cytotoxicity–Chinese Hamster Ovarian cells | In vivo cell tracking | [190] | |
Multiple NPs morphologies by controlling reaction time and polymer chain length in one preparation (spherical, worm, vesicle) | |||||||
ROS-responsive fluorinated polymers | Polymer by ATRP and NPs by self-assembly | 2,2,2-trifluoroethyl methacrylate | H and F NMR, FMRI, DLS (62, 32 and 18 nm), UV-Vis | Enhanced sensitivity for acidic microenvironment and the presence of ROS | ROS/pH dual-responsive 19F MRI agent | [191] | |
The concentration of H2O2 studied (~1 M) were higher than biological levels (50–100 μM) | |||||||
6-step synthesis that requires purification | |||||||
“OFF–ON” regulation of NPs to acidic environment | |||||||
Amino activable nanoprobe- p(mPEGMA)-co-poly(AMA-DNBS-F) (PEDF nanoprobe) | Copolymers by RAFT polymerisation and nanoprobe by nanoprecipitation | Trifluoromethyl-containing segments | H and F NMR, DLS (33 nm), FMRI, TEM, FTIR, CLSM, in vivo imaging in tumours–xenograft tumour models in mice | 2 step preparations for monomers | In vivo bio-thiols imaging | [192] | |
Highly sensitive to bio-thiols | |||||||
Water soluble | |||||||
Fluorinated block copolymers NPs | RAFT for the block polymers and NPs by self-assembly in aqueous solution | 2,2,2-trifluoroethylamide L-arginine methacrylamide | H, F- NMR, DLS (25 to 60 nm), TEM | Fluorinated functionalities in the hydrophilic shell | MRI Imaging | [300] | |
Increased T2 | |||||||
19F MRI-detectable drug delivery system | Layer-by-layer technique deposition of polyelectrolyte shells on nanoemulsion drops | Polyelectrolyte Nafion–fluorinated anionic polymer | DLS (170 nm), LDV, NTA, C-SEM, QCM, FMRI | Sufficient SNR ratio | Passive tumour targeting and drug delivery | [193] | |
Highly cationic particle (+68 ± 5 mV) | |||||||
Self-assembled 19F nanoprobes | Self-assembly of amphiphilic redox-responsive 19F-containing polymers and NIR-absorbing ICG molecules | 3,5-Bis(trifluoromethyl) benzoic acid part in the polymer | TEM, DLS (40 nm), UV–Vis, FNMR and MRI, TEM | Water-soluble | Accurate sensing and imaging of tumours | [66] | |
In vivo and in vitro studies–HepG2 tumour-bearing cells and mice | |||||||
High SNR ratio | |||||||
Good biocompatibility | |||||||
5 steps for preparation with purification requirement and moderate yield | |||||||
Novel system which has potential to be extended for imaging other tumour targets | |||||||
Multi-functional fluorocarbon NPs | Single and double emulsion | PFD, PFH, perfluorooctane, PFOB, PFCE | DLS (200 nm–200 µm), SEM, CM, FC, FI, FMRI, Cell viability–primary human dendritic cells, histology |
Customizable NPs, minimal toxicity | In vivo imaging and targeting applications | [194] | |
Size smaller than 200 nm is not formed by this NP formation | |||||||
PLGA PFPE | Emulsification (Sonicator)–1:1 molar ratio of autoclaved PFPE and sterile filtered Pluronic | PFPE | DLS (103 nm), FNMR and MRI, FM, cellular viability–diabetogenic mice T cells | Specificity for the labelled cells | Non-invasive monitoring the trafficking of cellular therapeutics | [195] | |
Reliable estimates of the apparent number of cells from image data | |||||||
PFCE encapsulated PLGA | Single emulsion | PFCE | DLS, FNMR and MRI, SANS, animal studies–male Wistar rats, mouse, mice, cell studie–primary murine/human dendritic cells | Biocompatible NPs | US and 19F MRI | [197] | |
Better acquisition time | Murine cardiac 19F MRI/MRS | [199] | |||||
Obtains complimentary information when in combination with other imaging agents | In vivo PAI, 19F MRI and fluorescent imaging (FI) | [198] | |||||
NPs loaded with chemotherapeutic drugs could give it a theranostic effect, Resomer RG 502 H, lactide: glycolide molar ratio 48:52 to 52:48 is the mostly used PLGA. The other ratios of lactide: glycolide and also their end group might give interesting results. The encapsulation efficiency of PFC could be studied each time to better understand the sensitivity | FMRI and CT (with gold NPs) | [200] | |||||
SPECT/PET and 19F MRI | [204] | ||||||
Chitosan coated PLGA -PFOB NPs | Single emulsion by homogenisation followed by sonication using 1.5% sodium cholate | PFOB | DLS (170 nm), CLSM, FC, FNMR and FMRI, TEM | Background-free signal compared to Gd (III) and super paramagnetic iron oxides NPs | Labelling and tracking therapeutic cells in vivo | [206] | |
As chitosan coating is just a physical adsorption, the stability of it has to be verified in biological environment | |||||||
Size of NPs is increased (200–400 nm) after the chitosan coating | |||||||
PEGylated PLGA NPs (PLGA NP (NIR700 + PFC)-PEG-800 CW | O/W emulsion and solvent evaporation-extraction method | PFCE | DLS (240–250 nm), TEM, FMRI, TEM, FM, histology, cell culture–murine breast carcinoma cell line | Quantitative 3D information from deeper tissues | In vivo imaging | [212] | |
Rapid qualitative optical monitoring | |||||||
PLGA–PEG folate-receptor-targeted NPs | Single emulsion-evaporation (1.5% sodium cholate surfactant) | PFOB | DLS (150 nm), FC, CLSM, F MRI, NIRS, CyA-KB cells | Encapsulate imaging agent and drug | Theranostic NP | [207] | |
Insufficient SNR in vivo for FMRI | |||||||
The loading capacity of the NPs is low for doxorubicin and ICG (0.04% and 0.127%) | |||||||
Doxorubicin-conjugated PFPE NPs | Polymers by RAFT polymerization | PFPE | DLS (8.1, 9.3 and 8.3), FNMR, MD | Improved cellular uptake | Improved therapeutic efficacy | [222] | |
Deep tumour penetration | |||||||
Studies done using 3D tumour spheroids | |||||||
F3-PLGA and F9-PLGA | Nanoprecipitation–surfactant free | Fluorinated PLGA (2,2,2-trifluoroethanolamine, nonafluoro-t-butoxyethylamine) | DLS (~54 nm and 58 nm), TEM, F NMR, FM, CyA–immortalized human glomerular endothelial cells and podocytes | No surfactant used | Theranostic NPs | [217] | |
Encapsulate hydrophobic drugs | |||||||
The reaction yield of the fluorinated polymer is not understood | |||||||
HYPERBRANCHED | Multifunctional hyperbranched polymers containing 19F | RAFT polymerization for polymer, NPs by self-assembly in water | 2,2,2-trifluoroethylacrylate | DLS (∼13 nm), GPC, TEM, FNMR and MRI, CT | Direct dissolution in water | Quantitative 19F MRI CA | [232] |
Biodegradable | |||||||
3 step preparation and the final product is not pure (3 mixture products) | |||||||
FNMR with multiple peaks | |||||||
T2 shortened | |||||||
PFPE based hyperbranched NPs conjugated with targeting aptamers | RAFT polymerization–for NPs, click chemistry for aptamers attaching | PFPE | F-DOSY (<10 nm), FM, FC, CrM, MD, FNMR and MRI | Superior MR imaging sensitivity and fluorine content -breast cancer cells | Quantitative 19F MRI CA | [233] | |
Low-cost fluorescence imaging | |||||||
Unsuitable for long term studies due to faster clearance from the body | |||||||
Accumulation of polymer in the liver was observed after 48 h and the 19F signal could be still detected in the liver | |||||||
Fluorinated hyperbranched polyether copolymers | ROMBP and copolymerization for polymers and self-assembly of the colloids | 2-[(2,2,2-trifluoroethoxy) methyl]oxirane/epifluorohydrin | DLS (160–200 nm), H NMR and F MRI, FM, HPLC, cytotoxicity studies - immortalized human glomerular endothelial cells and immortalized human podocytes | Repair damaged kidney glomerular cells in vitro | New generation 19F MRI nanotheranostics | [234] | |
Negligible cytotoxicity | |||||||
Narrow size distribution | |||||||
Relatively long T1 | |||||||
Higher amount of F gives less SNR | |||||||
DENDRIMERS | Fluorinated Gd(III)-DOTA complexes | Convergent synthesis for polymer and self-assembly for NPs | Fluorinated amino acid group | F NMR, DOSY, H and F MRI, KB cells for in vitro cytotoxicity study, animal imaging—Sprague Dawley female rats | Substantial improvement in relaxation rate and SNR ratio | CA for high field imaging | [239] |
Easily cleared through the kidneys | |||||||
The fluorine in the surface layer of dendrimers is toxic which can be diminished by burying the fluorine further into the dendrimer interior | |||||||
Second-generation dendron | Sonogashira coupling, alkyne deprotection and CuAAC | PFTB group attached to the dendron | FNMR | Higher number of equivalent fluorine than commercially available 19F MRI probes | Probes for 19F MRI | [240] | |
Too unpolar to be water-soluble | |||||||
Just one characterisation technique used | |||||||
Pseudo-symmetrical fluorines dendrimers | Polymer prep–bromination and Williamson ether synthesis, NPs by self-assembly | Bis(4-fluorophenyl) trifluoromethyl carbinol group | FNMR and MRI | Large amount of fluorine with a single NMR peak | 19F MRI-guided drug therapy | [241] | |
Optimize 19F relaxation time | |||||||
High sensitivity | |||||||
Reliable quantification | |||||||
Comparatively low yield (8%) for 11 synthesis steps | |||||||
Self-assembled fluorinated amphiphiles | Convergent way–Sonogashira coupling and Williamson ether synthesis for polymer, NPs by self-assembly | Fluorinated benzyl group | FNMR, DLS (6.3 nm), TEM | Quantifying drugs, detecting drug microenvironments and weak interactions | 19F NMR/MRI guided drug therapy. | [242] | |
Several synthetic step for the preparation with most of them requiring separation | |||||||
NANOHYDROGELS | Chitosan | Ionic gelation using hyaluronic acid and tripolyphosphate | 4,4,4-trifluorobutyric acid | DLS (274 nm), ELS (+30 mV), FNMR (−66 ppm), HNMR, TGA, DOSY, IR | Good biocompatibility toward murine macrophages cell line | Chitosan drug delivery systems for MRI lymphography | [247] |
Degree of substitution is comparatively low (0.3% and 20%) and varies between different substitutes, and determination is laborious | |||||||
Diblock polymers | Self-assembly by heating in aqueous solution | Poly[N(2,2 difluoroethyl)acrylamide] | SLS (100 and 67 nm), TEM, C-TEM, FNMR | Good sensitivity | 19F MR imaging–angiogenesis imaging or the labelling of pancreatic islets | [248] | |
Non-cytotoxic for several cell lines | |||||||
Long synthesis steps for preparation of polymers | |||||||
Fluorinated amphiphilic polymers | Self-assembly of polymers–direct dissolution of amphiphilic polymers in PBS buffer | -CF3 groups attached to the chains of polymer | DLS (6- 14 nm), FNMR, FMRI–phantom and animal imaging, CM, CyA-HeLa cells | Enhancement in T2 relaxation times by increasing the segment mobility | Multimodal imaging and therapeutic applications. | [249] | |
Superhydrophilic 19F MRI CA | Hydrogel matrix attached to zwitterionic, fluorinated and alkynyl molecule by click chemistry | The fluorine atoms on trifluoromethyl groups | HMRS, FTIR, GPC, CD, Rheometer, SEM, FMRI, degradation study–female BALB/c mice, CyA-Dendritic cells, NIH 3T3 cells | Gelation properties of hydrogels unaffected by labelling CA | Real-time FMRI to precisely locate and quantify the degradation rate of hydrogel scaffolds in vivo | [250] | |
3D-stereoscopic and 2D-anatomical information | |||||||
LIPIDS | Antigen-loaded PFC particles | High-frequency mixing of the liquid PFC with a cationic lipid mixture-particles coat with PEG | PFH or PFCE | CM, TEM, F NMR, Cytotoxicity in transplanted pancreatic islets and beta cell-like cells and T-cell proliferation assay | Improving pancreatic islets transplantation technique | Theranostic PFC NPs | [255,256] |
Good cell viability and no change in cells’ phenotypical properties | |||||||
High resolution localization of transplanted cells | |||||||
The use of PFCE is better than PFH because the latter have 3 peaks in FNMR which reduces its sensitivity | |||||||
Thermally responsive lipid nano-emulsion | Nano-emulsion | Modified α-tocopherol | FNMR, DLS (50 nm), ZP | Proved that T2 changes more than T1 due to variation in temperature for FNMR | Potential tumour diagnosis | [258] | |
The temperature studied is extreme (37 and 42 °C) compared to real tumour | |||||||
Multifunctional paramagnetic PFC NP | Microfluidization | PFCE | DLS (132 nm), AFM, UV–vis, FM, cellular toxicity on bronchial epithelium, FC, clinical pathology, FMRI | Enhanced intratumoural penetration | PFC NP delivery from intravenous applications to intratracheal use (for lung cancer) | [259] | |
NPs stored under very special condition | |||||||
The lipid surfactant used have a laborious preparation | |||||||
The studied NPs contain Gd3+ as Gd-lipid chelates | |||||||
MICELLE | Fluorinated thermoresponsive assembled protein (F-TRAP) | Self-assembly micelle | Fluorinated amino acids within a protein (5,5,5-DL-trifluoroleucines) | DLS (30 nm), FA, SLS, CD, MALDI-TOF-MS, TEM, turbidometry, FNMR, FMRI, Animal studies-mouse xenograft model of human breast cancer | No change in T1 | Thermoresponsive 19F MRI/MRS-traceable theranostic agents | [260] |
Doxorubicin encapsulation and thermoresponsive release | |||||||
Zero echo time 19F MRI was used to get the direct imaging of protein as after micelle formation, there is a reduction in T2 | |||||||
The release of drug is at 45 °C (usually tumour temperature range is 37 °C to 39 °C) | |||||||
INORGANIC | Gold NPs protected by fluorinated ligands (F- MPC) | Homogeneous phase synthesis | Fluorinated tetraethylene glycol part of the ligand | DLS (10 nm), TEM, HAADF-STEM, FNMR, UV-Vis, ESR, CLSM, cell interaction with HeLa cells | Elimination of the use of surfactants | Nanovector | [266] |
Size may help to reach small vasculature vessels | |||||||
Soluble in many organic solvents | |||||||
The preparation of fluorinated ligands contains 6 steps, most of them requiring purification | |||||||
Functionalized gold NPs | Homogeneous phase synthesis | Fluorinated tetraethylene glycol part of the ligand | DLS, HNMR, TEM (1.5–2 nm), UV-Vis, FNMR and MRI | Water-soluble | Dual 1H/19F MRI | [267] | |
Good quality MRI images | |||||||
Same as ref [266] + Gd(III) is embedded deep in the layer of Au NPs that causes reduction in T1 relaxation times of bulk water proton | |||||||
Gold NP functionalised with fluorine atoms | Reduction of HAuCl4 in the presence of NaBH4 | PFTB | ICP-MS, F-NMR/MRI, UV-Vis, TEM, Cell viability and apoptosis assays -MDA-MB-231, C33-A and MDA-MB-435S cell lines, MTS CyA | Colloidal stability in water and other solvents | 19F MR imaging | [268] | |
Single chemical shift | |||||||
Long storage | |||||||
High fluorine loading | |||||||
Long preparation and purification procedure for the fluorine ligands | |||||||
The position of fluorine in the NPs is not established | |||||||
Hollow mesoporous silica NPs (HMSN-PFCE) | Modified protocol from [301] | PFCE | DLS, SEM (290 nm), TEM, MRI, NMR, PAGE | Prolonged circulation time | Dual MRI (1H and 19F) | [270] | |
Helps in understanding the effect of loading agent on the biodistribution of NPs | |||||||
Better biodistribution of NPs | |||||||
The study is majorly applicable to systems whose cargo is on the outer surface | |||||||
Fluorinated mesoporous silica NPs (FMSNs and polyFMSNs) | Repeated impregnation-calcination process | Fluorosilane or polyfluorosiloxane | TGA, TEM (140 nm), DLS, FNMR and MRI, XPS, relaxometric properties | Colloidal stability | Dual MRI (1H and 19F) | [273] | |
Increase in 19F relaxivities | |||||||
Meticulous NPs preparation | |||||||
Contains Gd3+ | |||||||
The detection of probe might be impeded by the strong reduction of T2 after NPs formation | |||||||
PEG modified silica NP | Dehydration polymerizing reaction–PFCE including micelle as a platform | PFCE | TEM, DLS (50 nm), 1H/19F MRI | High sensitivity | Tumour imaging | [274] | |
Water stability | |||||||
Information on long term stability, encapsulation efficiency of PFCE is deficient | |||||||
Silica multifunctional core–shell NPs (FLAMEs) | PFCE-phospholipid nanoemulsion by sol-gel process using a novel surfactant, PAP | PFCE | DMS (76 nm), F NMR and MRI, TEM, biocompatibility by MTT assay-colon-26 cells, Passive targeting, and accumulation- mice bearing a tumour |
High sensitivity | Detection of gene expression and in vivo tumour imaging | [277] | |
Modifiability of the surface, biocompatibility | |||||||
In vivo stability | |||||||
The FLAME NPs needs to be PEGylated as naked NPs is trapped immediately by the RES | |||||||
The information on long term stability of NPs is lacking | |||||||
Mesoporous FLAME (mFLAME) | PFCE emulsion by Sol–gel process | PFCE | DLS (165 nm), TEM, FNMR and MRI, CLSM, FC, MTT CyA-KB cells, FM | Ample cellular uptake and drug release in folate receptor-overexpressing tumour cells | Theranostic cancer treatment | [278] | |
Drug release abilities at lower pH. (pH 5) | |||||||
Efficient tumour cell internalization | |||||||
Gd3+ complexes on FLAME NPs surface (FLAME-SS-Gd3+) | Gd3+ complexes were attached to the FLAME surface by disulfide linkers | PFCE | DLS (53.4 nm), FNMR and MRI, ICP-AES | Smart nanoprobe–based on PRE effect | Novel 19F MRI probes that visualize reducing environments | [279] | |
In vivo imaging | |||||||
High SNR ratio | |||||||
PFC based 19F MRI nanoprobes (PFC@SiO2, FLAME) | PFC emulsion by sol–gel process | PFCE, PFOB, FC-43, PFN, PFDCO, TPFBME | DLS, TEM (40–120 nm), FI-RAW264.7 cells, H MRI and FMRI, hepatic uptake in mouse | T2 values -relatively longer than polymer-based or inorganic 19F MRI nanoprobes | Multicolour MRI probes | [281] | |
In vivo triple-colour 19F MRI | |||||||
The shelf-life information is lacking for the NPs | |||||||
Fluorinated paramagnetic CAs | Multistep synthesis–cycloaddition reaction | Nonafluorinated carboxylic acid | FNMR, relaxivity measurements, MD | Relaxation times depending on the lanthanide ion | 19F MRI | [35] | |
Low solubility in aqueous media | |||||||
Hexagonal-phase NaGdF4:Yb3+/Tm3+ NPs | Hydrothermal method | NH4F/NaF | XRD, SEM, EDX, UV, photoluminescence spectra, EPR | Conducive to the UV light | IR tomography and MRI | [261] | |
Good water solubility | |||||||
Lanthanide-based upconversion NPs | |||||||
Inorganic nanocrystals-PEG-coated CaF2 nanocrystals | Solvothermal approach | CaF2 | H and C and F-NMR, DLS (<10 nm), TEM, XRD, EDX, FTIR, TGA, mouse model of inflammation | Maximal 19F density | Imaging tracers for in vivo 19F MRI | [263] | |
Average out homonuclear dipolar interactions | |||||||
Direct and real-time in vivo 19F MRI | |||||||
Chemically surface modifiable | |||||||
Long T2 | |||||||
Halloysite nanotubes- benzeneboronic acids (HNTs-6FBB) | One-pot synthesis | 3,5-bis(trifluoromethyl) benzeneboronic acid |
FNMR (−60 ppm), XRD, FTIR, XPS, TEM, EA (0.31% F) | Relatively long T2 | Selective response toward H2O2 | [285] | |
Water dispersibility | |||||||
Detection of H2O2 is based on a very minute shift in FNMR (0.2 ppm) | |||||||
Low cell cytotoxicity | |||||||
MIXED/HYBRID | Fe(III) tris-β-diketonate with PFPE (‘FETRIS’) | Microfluidization –metal-binding β-diketones conjugated to PFPE using pluronic surfactant | PFPE and PFPE derivatives, PFOB | DLS (140 nm to 200 nm), FNMR and FMRI, cell labelling-rodent glioma cell line | Ability to tune T1 by Fe concentration | In vivo detection of cell therapies and inflammatory cells | [288] |
Low cytotoxicity | |||||||
Small rates of metal leakage in the presence of EDTA in vitro and after cell labelling | |||||||
Cu1.75S–19F@OFP–SiO2 | One-pot encapsulation method-PFCE anchored to Cu1.75S NPs and trapped within the silica shell | PFCE | DLS (20.8 nm), TEM, FMRI, PTT | Ultrahigh F signal | Ablation and sensitive multimodal imaging | [290] | |
Biocompatible | |||||||
Capable of both in vivo imaging (F-MRI) and photothermal ablation | |||||||
Presence of excess of metals in a single probe! | |||||||
The degradation of this complex should be evaluated since without the SiO2 coating it is cytotoxic | |||||||
Fluorinated POSS-star polymers | Synthesis of star polymers by RAFT polymerization and polymer formation in water | 2,2,2-Trifluoroethyl acrylate in the ligands attached to POSS | DLS (8–10 nm), FNMR and FMRI | High imaging intensity | Theranostic agents for cancer diagnosis and treatment | [291] | |
No surfactants | |||||||
The yield for the formation of star polymers is low and extreme conditions for preparation | |||||||
Hybrid of fluorinated graphene oxide and iron oxide (IFGO) | Graphene oxide-Hummer’s method. Hybrid–co-precipitation | Fluorinated graphene | DLS (8–10 nm), FMRI, XRD, XPS, SEM and HRTEM, FTIR, MTT CyA-benign breast epithelial cell line, Raman, UV-Vis, hysteresis | Additional imaging modality–magnetic targeted drug delivery | Superior CAs for MRI and fluorescent imaging | [292] | |
Increased magnetic saturation-better contrast | |||||||
Cu7S4−Au heterodimer Cu7S4−Au@PSI−19F/PEG nanocomposites | Wet-chemical method for Cu7S4-Au nano seeds followed by click chemistry | 2,2,2-trifluoro-N-2-propyn-1-yl-acetamide | DLS, HRTEM (27 nm), XRD, EDX, HAADF-STEM, XPS, STEM, F NMR and MRI, CT, cell viability-4T1 cell lines, PTT–liver of female mice | Deep penetration | Multimodal imaging guided photothermal therapy | [293] | |
High spatial resolution | |||||||
Enhances the photothermal efficacy | |||||||
Long preparation for the nanocomposite | |||||||
Mn-LDH@PFPE NPs | Composite system by conjugating a PFPE onto the surface of manganese-incorporated layered double hydroxide | PFPE | NMR and MRI, DLS (10 nm), TEM, GPC, CM, MTT assay–MDA-MB- 468 breast cancer cells, histopathologic examination | High specificity to breast cancer cells | Potential “smart” 19F MRI agent for detection of cancer diseases | [297] | |
Fe3+@F,N-CD (fluorine and nitrogen co-doped carbon dot) | Simple microwave-assisted thermal decomposition method–from glucose and levofloxacin | Levofloxacin | DLS (16 nm), TEM, GPC, FTIR, XPS, FM, ESR, cytotoxic studies–HeLa cells, In vivo experiments -4T1 tumour bearing BALB/c mice, FMRI, CLSM | High T1 relaxivity | T1-weighted MRI CA | [298] | |
Strong photoluminescence | |||||||
Low synthetic cost | |||||||
Low toxicity | |||||||
Cannot be used for long term imaging in the body as they are excreted in a very short time from the body |